SGLT2 inhibitor trials for Type 2 diabetes

All SGLT2 inhibitor trials · All Type 2 diabetes trials

Phase breakdown

Recruiting trials studying SGLT2 inhibitor for Type 2 diabetes

• Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
  NCT07309094 · Phase: Not specified · Ages: 18 Years to 90 Years · Sex: All (male and female) · 1 location
• Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes
  NCT06838286 · Phase: Not specified · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Mechanism of SGLT2 Inhibition in the Kidney
  NCT06291155 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
  NCT05390892 · Phase: Phase 4 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 36 locations
• SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study
  NCT05770687 · Phase: Not specified · Ages: 19 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study SGLT2 inhibitor for Type 2 diabetes?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.